Answer
Yes, severe immune-related nephritis (kidney inflammation) and renal dysfunction (impaired kidney function) have been observed with nivolumab + relatlimab, with most affected patients presenting with increased serum creatinine without symptoms.
Sources for this answer
- Opdualag 240 mg/80 mg concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked